IRIS
PICARDI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 13.158
NA - Nord America 2.236
EU - Europa 966
SA - Sud America 467
AF - Africa 57
OC - Oceania 28
Totale 16.912
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 10.647
US - Stati Uniti d'America 2.115
CN - Cina 1.228
HK - Hong Kong 792
BR - Brasile 348
VN - Vietnam 260
GB - Regno Unito 253
IT - Italia 210
DE - Germania 151
CA - Canada 69
IN - India 62
FI - Finlandia 59
NL - Olanda 50
AR - Argentina 49
PL - Polonia 39
MX - Messico 33
ID - Indonesia 32
TR - Turchia 32
FR - Francia 29
ES - Italia 28
ZA - Sudafrica 28
EC - Ecuador 27
UA - Ucraina 27
AU - Australia 26
CZ - Repubblica Ceca 25
RU - Federazione Russa 24
JP - Giappone 17
CH - Svizzera 11
BD - Bangladesh 10
CL - Cile 10
CO - Colombia 10
SE - Svezia 10
SA - Arabia Saudita 7
VE - Venezuela 7
AT - Austria 6
BE - Belgio 6
PY - Paraguay 6
BY - Bielorussia 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
IQ - Iraq 5
LT - Lituania 5
PH - Filippine 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
LB - Libano 4
MA - Marocco 4
MY - Malesia 4
PE - Perù 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BH - Bahrain 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
IR - Iran 3
JO - Giordania 3
KR - Corea 3
OM - Oman 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
CM - Camerun 2
EE - Estonia 2
GT - Guatemala 2
HT - Haiti 2
HU - Ungheria 2
IE - Irlanda 2
IS - Islanda 2
KH - Cambogia 2
KZ - Kazakistan 2
MW - Malawi 2
PK - Pakistan 2
RS - Serbia 2
SI - Slovenia 2
TL - Timor Orientale 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BF - Burkina Faso 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GN - Guinea 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
ML - Mali 1
Totale 16.895
Salva come PNG Salva come JPEG
Città #
Singapore 874
Hong Kong 775
Ashburn 606
Hefei 494
Boardman 265
Beijing 237
Dallas 222
London 203
Shanghai 190
Ho Chi Minh City 103
Munich 87
Rome 85
Los Angeles 75
Council Bluffs 73
San Francisco 61
Hanoi 44
São Paulo 44
West Jordan 41
Seattle 39
Toronto 39
Turku 38
Warsaw 36
Santa Clara 35
Pune 32
Washington 31
Amsterdam 28
New York 26
Brno 22
Mexico City 22
Helsinki 21
Sona 20
Brooklyn 19
Boston 17
Montreal 16
Haiphong 15
Rio de Janeiro 15
Tokyo 14
Atlanta 13
Johannesburg 13
Da Nang 12
Guangzhou 12
Brasília 11
Central 11
Guayaquil 11
Manchester 11
Melbourne 11
Chennai 10
Chicago 10
Paris 10
Thái Bình 10
Canberra 9
Milan 9
Stockholm 9
Charlotte 8
Curitiba 7
Frankfurt am Main 7
San Jose 7
Ankara 6
Haikou 6
Moscow 6
Ninh Bình 6
Quito 6
Redmond 6
Riyadh 6
Belo Horizonte 5
Denver 5
Hải Dương 5
Jinan 5
Poplar 5
Secaucus 5
Thái Nguyên 5
Vienna 5
Zhengzhou 5
Berlin 4
Bogotá 4
Buenos Aires 4
Bắc Giang 4
Campinas 4
Copenhagen 4
Delhi 4
Hanover 4
Jakarta 4
Naples 4
Orem 4
Phoenix 4
Porto Alegre 4
Salvador 4
Sydney 4
Tashkent 4
The Dalles 4
Xingtai 4
Amman 3
Bangkok 3
Barra Mansa 3
Biên Hòa 3
Bologna 3
Brownsville 3
Buffalo 3
Camden 3
Cao Lanh 3
Totale 5.351
Salva come PNG Salva come JPEG
Nome #
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 229
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 213
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 211
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 206
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 206
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 204
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 203
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 203
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 203
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 202
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 200
[Consensus interferon: a new weapon in the treatment of chronic hepatitis C] 199
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 199
[Protective effect of verapamil in myocardial hypertrophy due to aortic stenosis experimentally induced in the rat] 198
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 196
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 196
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 194
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 194
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 193
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 192
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 192
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 191
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 188
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 188
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 186
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 184
Assessment of liver function by the exhaled breath-print during chronic liver disease 183
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 183
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 183
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 182
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 178
Blood glucose monitoring in the normal population: the PREDICA study 178
Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon 175
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 173
[Hepatocarcinoma: from epidemiology to gene therapy] 172
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 169
ALEX (R) (artificial liver for extracorporeal xenoassistance): A new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model 165
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 138
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 117
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 115
GH-resistance in different stages of chronic liver disease 113
Anestesia e malattie non comuni 112
Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes 110
Diabetes in chronic liver disease: from old concepts to new evidence 110
Enhanced portal flow velocity and volume following Iloprost treatment 108
[A 73-year-old woman with vomiting and metabolic alkalosis] 107
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 106
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 106
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 103
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 103
Radiofrequency ablation of hepatic tissue: a new experimental animal model 103
Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I 102
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 101
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 100
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 99
A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats 99
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 98
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 98
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 98
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 97
A challenging alfa-fetoprotein in a cirrhotic patient 96
Anesthesia & uncommon diseases 96
[A 61-year-old woman with abdominal pain and urination disorders] 95
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 94
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 94
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 93
[A 74-year-old woman with macrocytic anemia] 93
Breathprinting of liver diseases 93
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 93
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 92
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 90
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 90
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 88
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 87
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 87
Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support 87
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 86
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 86
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies: Haploidentical vs HLA Identical Transplantation in Hematologic Malignancies 86
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 85
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 84
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 83
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 83
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 78
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 78
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 76
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 74
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 72
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 68
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 68
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 63
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 62
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 60
The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population 56
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 54
Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia 51
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 51
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 50
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 50
Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study 49
Totale 12.675
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.963
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022394 0 2 9 0 3 3 4 5 35 10 5 318
2022/2023118 21 1 3 5 5 5 15 4 3 8 45 3
2023/2024824 51 54 25 78 77 333 3 37 13 76 28 49
2024/202512.233 146 74 306 50 192 279 163 39 646 801 4.413 5.124
2025/20263.415 773 390 548 874 357 473 0 0 0 0 0 0
Totale 16.984